An up-to-date overview of computational polypharmacology in modern drug discovery
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An up-to-date overview of computational polypharmacology in modern drug discovery
Authors
Keywords
-
Journal
Expert Opinion on Drug Discovery
Volume -, Issue -, Pages 1-20
Publisher
Informa UK Limited
Online
2020-05-26
DOI
10.1080/17460441.2020.1767063
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
- (2020) George M. Burslem et al. CELL
- First-in-Human Phase 1 Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients With Relapsed and Refractory Multiple Myeloma
- (2020) Ravi Vij et al. CLINICAL CANCER RESEARCH
- Improved protein structure prediction using potentials from deep learning
- (2020) Andrew W. Senior et al. NATURE
- Coronavirus puts drug repurposing on the fast track
- (2020) Charlotte Harrison NATURE BIOTECHNOLOGY
- Network-Based Assessment of Adverse Drug Reaction Risk in Polypharmacy Using High-Throughput Screening Data
- (2019) Guillermo de Anda-Jáuregui et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hit Dexter 2.0: Machine-Learning Models for the Prediction of Frequent Hitters
- (2019) Conrad Stork et al. Journal of Chemical Information and Modeling
- Acquired Resistance to Antibody-Drug Conjugates
- (2019) Denis Collins et al. Cancers
- Network-based prediction of drug combinations
- (2019) Feixiong Cheng et al. Nature Communications
- Harnessing Polypharmacology with Medicinal Chemistry
- (2019) Maria Laura Bolognesi ACS Medicinal Chemistry Letters
- Systematic computational identification of promiscuity cliff pathways formed by inhibitors of the human kinome
- (2019) Filip Miljković et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- MolTarPred: a web tool for comprehensive target prediction with reliability estimation
- (2019) Antonio Peón et al. Chemical Biology & Drug Design
- First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma
- (2019) Christophe Massard et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Therapeutic gene editing in haematological disorders with CRISPR/Cas9
- (2019) Trine I. Jensen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Design of Natural‐Product‐Inspired Multitarget Ligands by Machine Learning
- (2019) Francesca Grisoni et al. ChemMedChem
- Histone Deacetylase Inhibitors as Multitarget Ligands: New Players in Alzheimer's Disease Drug Discovery?
- (2019) Angela De Simone et al. ChemMedChem
- IBM Watson, heal thyself: How IBM overpromised and underdelivered on AI health care
- (2019) Eliza Strickland IEEE SPECTRUM
- Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
- (2019) Junting Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- The global pipeline of cell therapies for cancer
- (2019) Jia Xin Yu et al. NATURE REVIEWS DRUG DISCOVERY
- Epigenetic Modulators as Potential Multi-targeted Drugs Against Hedgehog Pathway for Treatment of Cancer
- (2019) Anshika N. Singh et al. PROTEIN JOURNAL
- KinomeX: a web application for predicting kinome-wide polypharmacology effect of small molecules
- (2019) Zhaojun Li et al. BIOINFORMATICS
- Machine learning with the TCGA-HNSC dataset: improving usability by addressing inconsistency, sparsity, and high-dimensionality
- (2019) Michael C. Rendleman et al. BMC BIOINFORMATICS
- Deep Learning Enhancing Kinome-Wide Polypharmacology Profiling: Model Construction and Experiment Validation
- (2019) Xutong Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epigenetic polypharmacology: A new frontier for epi-drug discovery
- (2019) Daniela Tomaselli et al. MEDICINAL RESEARCH REVIEWS
- Phenotype-based screens with conformation-specific inhibitors reveal p38 gamma and delta as targets for HCC polypharmacology
- (2019) Jia Xin Yu et al. MOLECULAR CANCER THERAPEUTICS
- High Impact: The Role of Promiscuous Binding Sites in Polypharmacology
- (2019) Cerisier et al. MOLECULES
- BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
- (2019) William Farnaby et al. Nature Chemical Biology
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- From machine learning to deep learning: Advances in scoring functions for protein-ligand docking
- (2019) Chao Shen et al. Wiley Interdisciplinary Reviews-Computational Molecular Science
- Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology
- (2019) Hansaim Lim et al. PLoS Computational Biology
- Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer Patients
- (2019) David E. Gerber et al. CLINICAL CANCER RESEARCH
- PROTACs– a game-changing technology
- (2019) Markella Konstantinidou et al. Expert Opinion on Drug Discovery
- Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanoma
- (2019) Shahneen Sandhu et al. INVESTIGATIONAL NEW DRUGS
- Data-Driven Construction of Antitumor Agents with Controlled Polypharmacology
- (2019) Chenxiao Da et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Clinical lessons learned from the first leg of the CAR T cell journey
- (2019) Robbie G. Majzner et al. NATURE MEDICINE
- A triple drug combination targeting components of the nutrient-sensing network maximizes longevity
- (2019) Jorge Iván Castillo-Quan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody–Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer
- (2019) Sung-Bae Kim et al. Targeted Oncology
- A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody–Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
- (2019) Brad S. Kahl et al. CLINICAL CANCER RESEARCH
- Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group
- (2019) Lisa M. Kopp et al. EUROPEAN JOURNAL OF CANCER
- LightGBM: An Effective and Scalable Algorithm for Prediction of Chemical Toxicity–Application to the Tox21 and Mutagenicity Data Sets
- (2019) Jin Zhang et al. Journal of Chemical Information and Modeling
- Novel tacrine–benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer’s Disease
- (2019) Gaia Fancellu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Targeted protein degradation: expanding the toolbox
- (2019) Matthieu Schapira et al. NATURE REVIEWS DRUG DISCOVERY
- Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics
- (2019) Yunxia Wang et al. NUCLEIC ACIDS RESEARCH
- Expression Atlas update: from tissues to single cells
- (2019) Irene Papatheodorou et al. NUCLEIC ACIDS RESEARCH
- Current progress and future perspectives of polypharmacology : From the view of non-small cell lung cancer
- (2019) Ramanathan Karuppasamy et al. SEMINARS IN CANCER BIOLOGY
- A phase 1 study of the antibody‐drug conjugate brentuximab vedotin with re‐induction chemotherapy in patients with CD30‐expressing relapsed/refractory acute myeloid leukemia
- (2019) Rupa Narayan et al. CANCER
- Multi-target dopamine D3 receptor modulators: Actionable knowledge for drug design from molecular dynamics and machine learning
- (2019) Mariarosaria Ferraro et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Target Associations for Polypharmacology from Analysis of Crystallographic Ligands of the Protein Data Bank
- (2019) Luca Pinzi et al. Journal of Chemical Information and Modeling
- Phase I Study of DSTP3086S, an Antibody-Drug Conjugate Targeting Six-Transmembrane Epithelial Antigen of Prostate 1, in Metastatic Castration-Resistant Prostate Cancer
- (2019) Daniel C. Danila et al. JOURNAL OF CLINICAL ONCOLOGY
- Repurposing human kinase inhibitors to create an antibiotic active against drug-resistant Staphylococcus aureus, persisters and biofilms
- (2019) Philipp Le et al. Nature Chemistry
- A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
- (2019) Sajid Khan et al. NATURE MEDICINE
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- Modeling polypharmacy side effects with graph convolutional networks
- (2018) Marinka Zitnik et al. BIOINFORMATICS
- 5-HT 2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology
- (2018) Yao Peng et al. CELL
- Combination Therapy for Multi-Target Manipulation of Secondary Brain Injury Mechanisms
- (2018) Mahadevabharath R. Somayaji et al. Current Neuropharmacology
- A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes
- (2018) Md Abdul Hye Khan et al. DIABETOLOGIA
- Rational Approaches for Combination Therapy Strategies Targeting the MAP Kinase Pathway in Solid Tumors
- (2018) Anthony W. Tolcher et al. MOLECULAR CANCER THERAPEUTICS
- Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer
- (2018) Jacqulyne P. Robichaux et al. NATURE MEDICINE
- Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder
- (2018) Weiwei Xue et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- Effect of missing data on multitask prediction methods
- (2018) Antonio de la Vega de León et al. Journal of Cheminformatics
- Binding site matching in rational drug design: algorithms and applications
- (2018) Misagh Naderi et al. BRIEFINGS IN BIOINFORMATICS
- Selection of protein conformations for structure-based polypharmacology studies
- (2018) Luca Pinzi et al. DRUG DISCOVERY TODAY
- Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
- (2018) Ewgenij Proschak et al. JOURNAL OF MEDICINAL CHEMISTRY
- Probing the chemical–biological relationship space with the Drug Target Explorer
- (2018) Robert J. Allaway et al. Journal of Cheminformatics
- Polypharmacology Browser PPB2: Target Prediction Combining Nearest Neighbors with Machine Learning
- (2018) Mahendra Awale et al. Journal of Chemical Information and Modeling
- Machine Learning Distinguishes with High Accuracy between Pan-Assay Interference Compounds That Are Promiscuous or Represent Dark Chemical Matter
- (2018) Swarit Jasial et al. JOURNAL OF MEDICINAL CHEMISTRY
- canSAR: update to the cancer translational research and drug discovery knowledgebase
- (2018) Elizabeth A Coker et al. NUCLEIC ACIDS RESEARCH
- Enhancing Molecular Promiscuity Evaluation Through Assay Profiles
- (2018) Sorin Avram et al. PHARMACEUTICAL RESEARCH
- The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis
- (2018) Jeff Janes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Privileged Structures and Polypharmacology within and between Protein Families
- (2018) Joshua Meyers et al. ACS Medicinal Chemistry Letters
- Network-Based Methods for Prediction of Drug-Target Interactions
- (2018) Zengrui Wu et al. Frontiers in Pharmacology
- Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
- (2018) Tsang-Pai Liu et al. Royal Society Open Science
- Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease
- (2017) Jakub Jeřábek et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery
- (2017) Balaguru Ravikumar et al. Expert Opinion on Drug Discovery
- Computational polypharmacology: a new paradigm for drug discovery
- (2017) Rajan Chaudhari et al. Expert Opinion on Drug Discovery
- A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer
- (2017) Hai-Yan Tu et al. LUNG CANCER
- Synergistic target combination prediction from curated signaling networks: Machine learning meets systems biology and pharmacology
- (2017) Huey Eng Chua et al. METHODS
- Engineered cell therapy for cancer gets thumbs up from FDA advisers
- (2017) Heidi Ledford NATURE
- Mastering the game of Go without human knowledge
- (2017) David Silver et al. NATURE
- Cancer systems biology: Harnessing off-target effects
- (2017) Gaye Saginc et al. Nature Chemical Biology
- Polypharmacology-based ceritinib repurposing using integrated functional proteomics
- (2017) Brent M Kuenzi et al. Nature Chemical Biology
- TRAPP webserver: predicting protein binding site flexibility and detecting transient binding pockets
- (2017) Antonia Stank et al. NUCLEIC ACIDS RESEARCH
- The target landscape of clinical kinase drugs
- (2017) Susan Klaeger et al. SCIENCE
- Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment
- (2017) Vanita Noronha et al. OncoTargets and Therapy
- Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology
- (2017) Kahina Hammam et al. Nature Communications
- The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand
- (2017) John D. Chan et al. Nature Communications
- ExCAPE-DB: an integrated large scale dataset facilitating Big Data analysis in chemogenomics
- (2017) Jiangming Sun et al. Journal of Cheminformatics
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Detecting similar binding pockets to enable systems polypharmacology
- (2017) Miquel Duran-Frigola et al. PLoS Computational Biology
- Molecular Connectivity Predefines Polypharmacology: Aliphatic Rings, Chirality, and sp3 Centers Enhance Target Selectivity
- (2017) Stefania Monteleone et al. Frontiers in Pharmacology
- Structural and Functional View of Polypharmacology
- (2017) Aurelio Moya-García et al. Scientific Reports
- Predicting unintended effects of drugs based on off-target tissue effects
- (2016) Docyong Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Spotting and designing promiscuous ligands for drug discovery
- (2016) P. Schneider et al. CHEMICAL COMMUNICATIONS
- Polypharmacology in Drug Development: A Minireview of Current Technologies
- (2016) Zhi Tan et al. ChemMedChem
- Getting the most out of PubChem for virtual screening
- (2016) Sunghwan Kim Expert Opinion on Drug Discovery
- AutoT&T v.2: An Efficient and Versatile Tool for Lead Structure Generation and Optimization
- (2016) Yan Li et al. Journal of Chemical Information and Modeling
- Boosting Docking-Based Virtual Screening with Deep Learning
- (2016) Janaina Cruz Pereira et al. Journal of Chemical Information and Modeling
- A comprehensive map of molecular drug targets
- (2016) Rita Santos et al. NATURE REVIEWS DRUG DISCOVERY
- A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer’s Disease Mice
- (2016) Mar Cuadrado-Tejedor et al. NEUROPSYCHOPHARMACOLOGY
- ChemProt-3.0: a global chemical biology diseases mapping
- (2016) Jens Kringelum et al. Database-The Journal of Biological Databases and Curation
- Badapple: promiscuity patterns from noisy evidence
- (2016) Jeremy J. Yang et al. Journal of Cheminformatics
- Epigenetic polypharmacology: from combination therapy to multitargeted drugs
- (2016) Angel R. de Lera et al. Clinical Epigenetics
- Comprehensive Modeling and Discovery of Mebendazole as a Novel TRAF2- and NCK-interacting Kinase Inhibitor
- (2016) Zhi Tan et al. Scientific Reports
- Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth
- (2015) Hassan Al-Ali et al. ACS Chemical Biology
- Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer’s Disease
- (2015) Rong Sheng et al. ACS Chemical Neuroscience
- IsoMIF Finder: online detection of binding site molecular interaction field similarities
- (2015) Matthieu Chartier et al. BIOINFORMATICS
- DOCK 6: Impact of new features and current docking performance
- (2015) William J. Allen et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Bispecific antibodies and their applications
- (2015) Gaowei Fan et al. Journal of Hematology & Oncology
- A global reference for human genetic variation
- (2015) Richard A. Gibbs et al. NATURE
- Dark chemical matter as a promising starting point for drug lead discovery
- (2015) Anne Mai Wassermann et al. Nature Chemical Biology
- STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data
- (2015) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology
- (2015) Michael K. Gilson et al. NUCLEIC ACIDS RESEARCH
- PubChem Substance and Compound databases
- (2015) Sunghwan Kim et al. NUCLEIC ACIDS RESEARCH
- BioGPS: Navigating biological space to predict polypharmacology, off-targeting, and selectivity
- (2015) Lydia Siragusa et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Engineering CAR-T cells: Design concepts
- (2015) Shivani Srivastava et al. TRENDS IN IMMUNOLOGY
- Systems biology approaches for advancing the discovery of effective drug combinations
- (2015) Karen A Ryall et al. Journal of Cheminformatics
- Comprehensive prediction of drug-protein interactions and side effects for the human proteome
- (2015) Hongyi Zhou et al. Scientific Reports
- Extended Graph-Based Models for Enhanced Similarity Search in Cavbase
- (2014) Timo Krotzky et al. IEEE-ACM Transactions on Computational Biology and Bioinformatics
- Curation and Analysis of Multitargeting Agents for Polypharmacological Modeling
- (2014) A. Srinivas Reddy et al. Journal of Chemical Information and Modeling
- GES Polypharmacology Fingerprints: A Novel Approach for Drug Repositioning
- (2014) Violeta I. Pérez-Nueno et al. Journal of Chemical Information and Modeling
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- SwissTargetPrediction: a web server for target prediction of bioactive small molecules
- (2014) David Gfeller et al. NUCLEIC ACIDS RESEARCH
- SuperPred: update on drug classification and target prediction
- (2014) Janette Nickel et al. NUCLEIC ACIDS RESEARCH
- LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures
- (2014) Qiaonan Duan et al. NUCLEIC ACIDS RESEARCH
- Adverse Drug Reaction Prediction Using Scores Produced by Large-Scale Drug-Protein Target Docking on High-Performance Computing Machines
- (2014) Montiago X. LaBute et al. PLoS One
- TargetHunter: An In Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database
- (2013) Lirong Wang et al. AAPS Journal
- Ado-trastuzumab emtansine approved for advanced breast cancer
- (2013) K. Traynor AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Insights into polypharmacology from drug-domain associations
- (2013) Aurelio A. Moya-García et al. BIOINFORMATICS
- APoc: large-scale identification of similar protein pockets
- (2013) Mu Gao et al. BIOINFORMATICS
- Structural Systems Pharmacology: A New Frontier in Discovering Novel Drug Targets
- (2013) Hepan Tan et al. CURRENT DRUG TARGETS
- Tox21 to Date: Steps toward Modernizing Human Hazard Characterization
- (2013) Kellyn S. Betts ENVIRONMENTAL HEALTH PERSPECTIVES
- Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats
- (2013) John D Imig et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- AutoGrow 3.0: An improved algorithm for chemically tractable, semi-automated protein inhibitor design
- (2013) Jacob D. Durrant et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Comparing the Chemical Structure and Protein Content of ChEMBL, DrugBank, Human Metabolome Database and the Therapeutic Target Database
- (2013) Christopher Southan et al. Molecular Informatics
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- DrugBank 4.0: shedding new light on drug metabolism
- (2013) Vivian Law et al. NUCLEIC ACIDS RESEARCH
- VisANT 4.0: Integrative network platform to connect genes, drugs, diseases and therapies
- (2013) Zhenjun Hu et al. NUCLEIC ACIDS RESEARCH
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- Growth of Ligand–Target Interaction Data in ChEMBL Is Associated with Increasing and Activity Measurement-Dependent Compound Promiscuity
- (2012) Ye Hu et al. Journal of Chemical Information and Modeling
- Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking
- (2012) Michael M. Mysinger et al. JOURNAL OF MEDICINAL CHEMISTRY
- NCATS launches drug repurposing program
- (2012) Malorye Allison NATURE BIOTECHNOLOGY
- The Promise of Antibody–Drug Conjugates
- (2012) Beverly A. Teicher et al. NEW ENGLAND JOURNAL OF MEDICINE
- idTarget: a web server for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approach
- (2012) Jui-Chih Wang et al. NUCLEIC ACIDS RESEARCH
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- A Critical Assessment of Combined Ligand- and Structure-Based Approaches to hERG Channel Blocker Modeling
- (2011) Lei Du-Cuny et al. Journal of Chemical Information and Modeling
- FRED Pose Prediction and Virtual Screening Accuracy
- (2011) Mark McGann Journal of Chemical Information and Modeling
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome
- (2011) Heng Luo et al. NUCLEIC ACIDS RESEARCH
- ChEMBL: a large-scale bioactivity database for drug discovery
- (2011) A. Gaulton et al. NUCLEIC ACIDS RESEARCH
- Bispecific Antibodies for Cancer Immunotherapy
- (2010) Dafne Müller et al. BIODRUGS
- A new protein binding pocket similarity measure based on comparison of clouds of atoms in 3D: application to ligand prediction
- (2010) Brice Hoffmann et al. BMC BIOINFORMATICS
- Role of hERG potassium channel assays in drug development
- (2010) Birgit Priest et al. Channels
- Molecular Scaffolds with High Propensity to Form Multi-Target Activity Cliffs
- (2010) Ye Hu et al. Journal of Chemical Information and Modeling
- Polypharmacology Directed Compound Data Mining: Identification of Promiscuous Chemotypes with Different Activity Profiles and Comparison to Approved Drugs
- (2010) Ye Hu et al. Journal of Chemical Information and Modeling
- PROMISCUOUS: a database for network-based drug-repositioning
- (2010) J. von Eichborn et al. NUCLEIC ACIDS RESEARCH
- PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach
- (2010) Xiaofeng Liu et al. NUCLEIC ACIDS RESEARCH
- PocketMatch: A new algorithm to compare binding sites in protein structures
- (2009) Kalidas Yeturu et al. BMC BIOINFORMATICS
- Target identification using drug affinity responsive target stability (DARTS)
- (2009) B. Lomenick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fragment-Based de Novo Ligand Design by Multiobjective Evolutionary Optimization
- (2008) Fabian Dey et al. Journal of Chemical Information and Modeling
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More